Emerald Health Therapeutics’ Verdélite Launches Souvenir™ Cannabis Brand in Québec
June 23, 2020 06:02 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, June 23, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that its Verdélite Sciences subsidiary in St....
Emerald Health Therapeutics Announces Pure Sunfarms’ Initial Cultivation and Sales License for Second Greenhouse
May 25, 2020 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, May 25, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that its joint venture for large-scale, low-cost,...
Emerald Health Therapeutics, Pure Sunfarms, and Village Farms Complete Settlement of All Disputes
March 09, 2020 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, March 09, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that, further to its news release dated March...
Emerald Health Therapeutics Reports Third Quarter 2019 Financial Results; Sales Double Third Quarter in a Row
December 02, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) reported financial results for the quarter and nine-month...
Emerald Health Therapeutics’ Pure Sunfarms JV Records Q3 Net Sales of $24.0 Million, 69% Gross Margin, 56% EBITDA Margin, Fourth Consecutive Quarter of Positive EBITDA, and $0.63/gram All-in Production Cost
November 15, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
Pure Sunfarms is #1 dried flower brand with Ontario Cannabis Store in October, with 16% market share and #1 selling product Emerald to report third quarter 2019 financial results on November 29th and...
Emerald Health Therapeutics to Participate in Cowen 2nd Annual Boston Cannabis Conference
October 31, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) will participate in the Cowen 2nd Annual Boston Cannabis...
Emerald Health Therapeutics Announces Internal Reorganization
October 30, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has announced an internal reorganization including the...
L'activité de commercialisation de cannabis de qualité supérieure au Québec d'Emerald Health Therapeutics reçoit une modification de licence permettant la vente directe de produits de marque
October 16, 2019 10:12 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, Colombie-Britannique, 16 oct. 2019 (GLOBE NEWSWIRE) -- Verdélite, le site de production de cannabis détenu à 100 % par Emerald Health Therapeutics (« Emerald »)(TSXV : EMH ; OTCQX :...
Emerald Health Therapeutics’ Québec Premium Cannabis Operation Receives Sale License Amendment, Allowing Direct Sales of Branded Products
October 16, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics’ (“Emerald”)(TSXV: EMH; OTCQX: EMHTF) wholly-owned production facility, Verdélite, in St. Eustache, Québec,...
Emerald Completes Issuance of Shares in Lieu of Cash Due for Verdélite Acquisition
May 27, 2019 08:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, May 27, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that the vendors (the "Vendors") of Verdélite...